Deep Dive: Deep Dive Into Immune Deficiency

As treatments for multiple myeloma continue to improve, clinicians must still face a scary reality for their patients: immune deficiency. Researchers and doctors alike are still trying to get a better understanding of which patients are more likely to have severe immune issues, which could lead to life-threatening infections. In this episode of Deep Dive, we’ll hear from Dr. Joshua Richter from the Tisch Cancer Institute at Mount Sinai, about his research in patients with myeloma who have a high burden of infection, and why patient-provider communication is essential in this setting.